These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 20478741)

  • 1. Insomnia severity is an indicator of suicidal ideation during a depression clinical trial.
    McCall WV; Blocker JN; D'Agostino R; Kimball J; Boggs N; Lasater B; Rosenquist PB
    Sleep Med; 2010 Oct; 11(9):822-7. PubMed ID: 20478741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissection of the factors driving the placebo effect in hypnotic treatment of depressed insomniacs.
    McCall WV; D'Agostino R; Rosenquist PB; Kimball J; Boggs N; Lasater B; Blocker J
    Sleep Med; 2011 Jun; 12(6):557-64. PubMed ID: 21601519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.
    McCall WV; Blocker JN; D'Agostino R; Kimball J; Boggs N; Lasater B; Haskett R; Krystal A; McDonald WM; Rosenquist PB
    J Clin Sleep Med; 2010 Aug; 6(4):322-9. PubMed ID: 20726279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
    J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective vs. subjective measurements of sleep in depressed insomniacs: first night effect or reverse first night effect?
    McCall C; McCall WV
    J Clin Sleep Med; 2012 Feb; 8(1):59-65. PubMed ID: 22334811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age.
    McCall WV; Mercado K; Dzurny TN; McCloud LL; Krystal AD; Benca RM; Rosenquist PB; Looney SW
    J Psychopharmacol; 2024 Sep; 38(9):827-831. PubMed ID: 39119911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
    Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
    Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder.
    Snedecor SJ; Botteman MF; Schaefer K; Sarocco P; Barry N; Pickard AS
    J Ment Health Policy Econ; 2010 Mar; 13(1):27-35. PubMed ID: 20571180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insomnia is associated with suicide attempt in middle-aged and older adults with depression.
    Kay DB; Dombrovski AY; Buysse DJ; Reynolds CF; Begley A; Szanto K
    Int Psychogeriatr; 2016 Apr; 28(4):613-9. PubMed ID: 26552935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M; Kinrys G; Krystal A; McCall WV; Roth T; Schaefer K; Rubens R; Roach J; Huang H; Krishnan R
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.
    Goforth HW; Preud'homme XA; Krystal AD
    Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Zhu L; Tao R; Hughes C; Croarkin P
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):21-8. PubMed ID: 22257126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing Suicidal Ideation Through Insomnia Treatment (REST-IT): A Randomized Clinical Trial.
    McCall WV; Benca RM; Rosenquist PB; Youssef NA; McCloud L; Newman JC; Case D; Rumble ME; Szabo ST; Phillips M; Krystal AD
    Am J Psychiatry; 2019 Nov; 176(11):957-965. PubMed ID: 31537089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of zolpidem-CR on the suicide item of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia and suicidal ideation: Lessons learned.
    McCall WV; Mercado K; Dzurny TN; McCloud LL; Krystal AD; Benca RM; Rosenquist PB; Looney SW
    Psychiatry Res; 2023 Dec; 330():115576. PubMed ID: 37922732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive Therapy Versus Fluoxetine in Suicidal Resolution for Patients With Major Depressive Disorder.
    Lin CH; Chen CC; Huang CJ
    J ECT; 2020 Dec; 36(4):234-241. PubMed ID: 32205736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.